Hemianopsia Market Size, Trends, Industry Profile, 2023-2032
Hemianopsia Market Size, Trends,  Industry Profile, 2023-2032

Hemianopsia Market Share, Size, Trends, Industry Analysis Report, By Type (Homonymous Hemianopsia, Quadrantanopsia, and Bitemporal Hemianopsia); By Treatment; By End User; By Region; Segment Forecast, 2023 – 2032

  • Published Date:Oct-2023
  • Pages: 116
  • Format: PDF
  • Report ID: PM3843
  • Base Year: 2022
  • Historical Data: 2019-2021

Report Outlook

The global hemianopsia market was valued at USD 335.87 million in 2022 and is expected to grow at a CAGR of 7.3% during the forecast period.

Significant growth in the number of people suffering from hemianopsia due to the surging prevalence of conditions such as traumatic brain injury, stroke, and tumors and a rising number of people becoming aware of several visual impairments like hemianopsia are among the primary factors fueling the demand and growth of the global market. In addition, the exponential rise in research and development activities and investments to develop cost-effective and innovative treatments addressing the needs of patients suffering from types of issues and greater demand for assistive technologies, such as wearable devices, digital aids, and mobility assistance tools, is contributing positively towards the market growth.

Hemianopsia Market Size

To Understand More About this Research: Request a Free Sample Report

Moreover, there is growing proliferation regarding the introduction of wearable devices, such as smart glasses or head-mounted displays, in order to assist individuals with hemianopsia, as these devices use real-time image processing and display techniques to provide visual field compensation, which improves the remaining visual field and improve functional vision, enabling individuals to navigate their surroundings more effectively is gaining traction.

The outbreak of the COVID-19 pandemic has significantly impacted the growth of the hemianopsia market. The rapid spread of the pandemic resulted in a shift in focus of healthcare systems towards the treatment of coronavirus. Thus, non-urgent medical appointments and elective procedures were often postponed or canceled, which might have led to delayed diagnosis and treatment for individuals with hemianopsia, potentially affecting the demand for related products and services.

Industry Dynamics

Growth Drivers

Technological Advancements

The significant advances in medical technology and rapid innovations in diagnostic tools, such as advanced imaging techniques and visual field-testing methods that can improve accuracy and efficiency in diagnosing hemianopsia, along with the development of neurorehabilitation therapies, including virtual reality, computer-based training, and neurostimulation techniques, enhancing the rehabilitation and management of the condition are the leading factors expected to boost the hemianopsia market growth.

Furthermore, the growing adoption of telemedicine and remote rehabilitation services across the globe and the prevalence of remote monitoring, virtual consultations, and home-based rehabilitation programs providing convenient access to healthcare services, especially for individuals who face geographical or mobility limitations, are also likely to impact the global hemianopsia market growth positively.


Report Segmentation

The market is primarily segmented based on type, treatment, end user, and region.

By Type

By Treatment

By End User

By Region

  • Homonymous Hemianopsia
  • Quadrantanopsia
  • Bitemporal Hemianopsia
  • Vision Restoration Therapy
  • Visual Field Expander Aid
  • Hospitals
  • Specialty Clinics
  • North America (U.S., Canada)
  • Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia)
  • Asia Pacific (Japan, China, India, Malaysia, Indonesia. South Korea)
  • Latin America (Brazil, Mexico, Argentina)
  • Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)

To Understand the Scope of this Report: Speak to Analyst

By Type

Homonymous hemianopsia segment accounted for the largest market share in 2022

The homonymous hemianopsia segment accounted for the largest global market share. The growth of the segment market can be mainly attributable to the widespread prevalence of homonymous hemianopsia as a common visual impairment resulting from various causes such as stroke, traumatic brain injury, tumors, and other neurological conditions, along with the introduction to improved diagnostic techniques and increased awareness among healthcare professionals that have led to earlier and more accurate detection of homonymous hemianopsia.

With the increasing focus on patient-centered care and improving the quality of life for individuals with visual impairments across the world, there is a growing demand for effective interventions to address these challenges, leading to the development and adoption of solutions targeting homonymous hemianopsia, including assistive technologies and rehabilitation programs.

The bitemporal hemianopsia segment is likely to grow at a significant growth rate over the next coming years due to increased awareness of bitemporal hemianopsia and its symptoms that lead to earlier diagnosis and treatment seeking and surging proliferation for improved access to healthcare services such as specialized ophthalmology clinics and neurosurgery centers.

By Treatment

Vision restoration therapy segment held the significant market share in 2022

The vision restoration therapy segment held the majority market share in terms of revenue in 2022, which is largely accelerated by the increasing number of patients with hemianopsia seeking treatments that can help improve their visual function and awareness about vision restoration therapy to address their condition. In addition, regulatory agencies or institutions have recognized the importance of vision restoration therapies for patients with hemianopsia and have provided guidance and support for the development and approval of innovative treatments in this field.

The visual field expanded aid segment is expected to gain a substantial growth rate over the study period, mainly attributable to the ability of these devices to offer enhanced customizable settings, improved optics, and better integration with eyewear, which makes them more user-friendly and comfortable, and have significantly expanded the possibilities for vision field expanders across the globe.

By End-Users

Specialty clinics segment is expected to witness highest growth rate during forecast period

The specialty clinics segment is projected to grow at a healthy growth rate during the anticipated period on account of the rapid increase in the number of specialty clinics offering advanced and innovative treatment and management of hemianopsia along with their capabilities to play a pivotal role in conducting clinical trials, implementing novel therapies, and adopting innovative rehabilitation programs, that attracts patients seeking access to these advancements.

The hospital's segment led the industry market with a substantial revenue share in 2022, which is largely accelerated by the growing prevalence of stroke and various other types of neurological disorders and the emergence of hospitals as primary centers for the treatment and diagnosis of these conditions. Additionally, hospitals are investing significantly in new technologies and equipment in order to provide advanced and improved treatment to their patients, which, as a result, propelling the segment market growth.

By Regional Analysis

North America region dominated the global market in 2022

The North American region dominated the global market with a considerable share. Region’s growth is accelerated due to the presence of highly developed healthcare facilities and well-equipped hospitals and a surge in the number of strokes in countries like the United States and Canada. The North America region has a well-established regulatory framework that supports the development and commercialization of medical devices and pharmaceuticals, which is positively influencing the region’s growth. For instance, according to the Centers for Disease Control and Prevention, approx. 795,000 people in the U.S. are suffering from stroke each year. About 610,000 strokes are new. Also, 1 in every six deaths from cardiovascular disease is due to stroke in the U.S.

APAC is expected to grow at a steady rate, owing to awareness about visual impairments, including hemianopsia, increases; more individuals are likely to seek diagnosis and treatment coupled with the advancements in medical facilities, diagnostic technologies, and rehabilitation centers, particularly in emerging economies like India, China, and Indonesia.

Competitive Insight

The Hemianopsia market is fragmented and is anticipated to witness competition due to several players' presence. Major service providers in the market are constantly upgrading their technologies to stay ahead of the competition and to ensure efficiency, integrity, and safety. These players focus on partnership, product upgrades, and collaboration to gain a competitive edge over their peers and capture a significant market share.

Some of the major players operating in the global market include

  • AbbVie Inc.
  • Aerie Pharmaceuticals Inc.
  • AkzoNobel N.V.
  • Carl Zeiss AG
  • Chadwick Optical
  • EyeTech Digital Systems
  • F. Hoffmann-La Roche Ltd.
  • Genetech Inc.
  • Healio
  • LumiThera Inc.
  • NeuroVision Imaging LLC
  • Novartis AG
  • NovaVision
  • RetroSense Therapeutics LLC
  • Samsung Medical Center
  • VisionCare Inc.
  • Vycor Medical Inc.

Recent Developments

  • In May 2023, Indian University School of Optometry, established new “Aniseikonia Clinic”, to treat patients with eye related problems.
  • In May 2021, the first commercial gene therapy startup, announced the launch of Vedere Bio II with a USD 77 million series A funding, in order to develop treatment for blindness & restore vision.

Hemianopsia Market Report Scope

Report Attributes


Market size value in 2023

USD 359.31 million

Revenue forecast in 2030

USD 676.29 million


7.3% from 2023 – 2032

Base year


Historical data

2019 – 2021

Forecast period

2023 – 2032

Quantitative units

Revenue in USD million and CAGR from 2023 to 2032

Segments covered

By Type, By Treatment, By End User, By Region

Regional scope

North America, Europe, Asia Pacific, Latin America; Middle East & Africa


Report customization as per your requirements with respect to countries, region and segmentation.


The hemianopsia market report covering key segments are type, treatment, end user, and region.

Hemianopsia Market Size Worth $676.29 Million By 2032.

The global hemianopsia market is expected to grow at a CAGR of 7.3% during the forecast period.

North America is leading the global market.

key driving factors in hemianopsia market are Increasing Incidence of Brain Injuries.